57 studies found for:    Open Studies | "Papilloma"
Show Display Options
Rank Status Study
21 Recruiting Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Procedure: therapeutic conventional surgery;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Drug: carboplatin;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
22 Recruiting Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage I Squamous Cell Carcinoma of the Oropharynx;   Stage II Squamous Cell Carcinoma of the Oropharynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Tongue Cancer
Interventions: Drug: docetaxel;   Radiation: intensity-modulated radiation therapy;   Radiation: hyperfractionated radiation therapy;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
23 Recruiting A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
Condition: Genital Human Papilloma Virus Infection
Intervention: Drug: Gardasil
24 Recruiting Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)
Conditions: Anogenital Human Papilloma Virus Infection;   Condyloma Acuminata
Interventions: Biological: V501;   Biological: Placebo
25 Unknown  3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in China
Condition: Anogenital Human Papilloma Virus Infection
Intervention:
26 Unknown  Acceptability and Feasibility of Human Papilloma Virus Vaccine
Condition: Cervical Cancer
Intervention: Behavioral: Health education
27 Recruiting Human Papilloma Viruses (HPV) Vaccine Adherence Community Clinic Study
Condition: Patient Compliance
Intervention: Behavioral: HPV Vaccine Electronic Reminders
28 Recruiting The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
Conditions: Chronic Kidney Disease;   Dialysis
Intervention: Drug: Human Papillomavirus Vaccine
29 Recruiting The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients
Conditions: Chronic Kidney Disease, Stage IV (Severe);   Chronic Kidney Disease, Stage V
Intervention: Biological: HPV-6/11/16/18 vaccine
30 Recruiting A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer
Condition: Oropharyngeal Cancer
Interventions: Procedure: TORS;   Radiation: Adjuvant Radiation Therapy
31 Unknown  Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population
Conditions: Patient With Invasive Cervical Carcinoma;   Patient With CIN Lesion;   Patient With HPV Infected Patients Without Histopathologic Lesion;   Normal Populations.
Intervention: Procedure: peripheral blood isolation
32 Not yet recruiting Human Papilloma Virus (HPV) Prevalence in the Mouth and Oropharynx of the General Population
Condition: Chronic Tonsillitis
Intervention:
33 Recruiting HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Conditions: AIN;   HIV
Intervention: Biological: Gardasil
34 Unknown  DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx
Condition: Head and Neck Cancer
Interventions: Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: polyacrylamide gel electrophoresis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: flow cytometry;   Other: immunoenzyme technique;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Other: pharmacological study
35 Not yet recruiting 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children
Condition: Recurrent Respiratory Papillomatosis
Intervention: Biological: 4-valent HPV vaccine
36 Recruiting Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients
Conditions: Squamous Cell Carcinoma of the Oropharynx;   HPV
Intervention: Radiation: Cetuximab
37 Recruiting Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer
Condition: HPV-16 +ve Oropharyngeal Carcinoma
Intervention: Biological: ADXS11-001
38 Recruiting Study of the Therapeutic Vaccine (ISA101) to Treat Advanced or Recurrent Cervical Cancer
Condition: Cervical Cancer
Intervention: Drug: ISA101
39 Recruiting Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Condition: Head and Neck Cancer
Interventions: Other: biologic sample preservation procedure;   Other: medical chart review
40 Unknown  MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Procedure: blood-oxygen-level-dependent functional magnetic resonance imaging;   Procedure: diffusion tensor imaging;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: functional magnetic resonance imaging;   Radiation: intensity-modulated radiation therapy;   Radiation: radiation therapy treatment planning/simulation

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-57) Show next page of results
Indicates status has not been verified in more than two years